SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SK Biopharmaceuticals Co Ltd
Operating Income Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Income
-â‚©37.5B
CAGR 3-Years
46%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Operating Income
â‚©26B
CAGR 3-Years
-36%
CAGR 5-Years
25%
CAGR 10-Years
-9%
Hanmi Science Co Ltd
KRX:008930
Operating Income
â‚©49.6B
CAGR 3-Years
18%
CAGR 5-Years
42%
CAGR 10-Years
10%
Hanmi Pharm Co Ltd
KRX:128940
Operating Income
â‚©262.4B
CAGR 3-Years
68%
CAGR 5-Years
25%
CAGR 10-Years
16%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Income
â‚©7.4B
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
-9%
C
Celltrion Pharm Inc
KOSDAQ:068760
Operating Income
â‚©22.2B
CAGR 3-Years
-18%
CAGR 5-Years
42%
CAGR 10-Years
13%

See Also

What is SK Biopharmaceuticals Co Ltd's Operating Income?
Operating Income
-37.5B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Operating Income amounts to -37.5B KRW.

What is SK Biopharmaceuticals Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
23%

Over the last year, the Operating Income growth was 71%. The average annual Operating Income growth rates for SK Biopharmaceuticals Co Ltd have been 46% over the past three years , 23% over the past five years .

Back to Top